Cargando…

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation

The conventional two-dimensional (2D) tumor cell lines in Petri dishes have played an important role in revealing the molecular biological mechanism of lung cancer. However, they cannot adequately recapitulate the complex biological systems and clinical outcomes of lung cancer. The three-dimensional...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yang, Wang, Yadong, Guan, Ai, Xue, Jianchao, Li, Bowen, Huang, Zhicheng, Zheng, Zhibo, Liang, Naixin, Yang, Yanlian, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993089/
https://www.ncbi.nlm.nih.gov/pubmed/36911198
http://dx.doi.org/10.3389/fbioe.2023.1132940
_version_ 1784902457217777664
author Song, Yang
Wang, Yadong
Guan, Ai
Xue, Jianchao
Li, Bowen
Huang, Zhicheng
Zheng, Zhibo
Liang, Naixin
Yang, Yanlian
Li, Shanqing
author_facet Song, Yang
Wang, Yadong
Guan, Ai
Xue, Jianchao
Li, Bowen
Huang, Zhicheng
Zheng, Zhibo
Liang, Naixin
Yang, Yanlian
Li, Shanqing
author_sort Song, Yang
collection PubMed
description The conventional two-dimensional (2D) tumor cell lines in Petri dishes have played an important role in revealing the molecular biological mechanism of lung cancer. However, they cannot adequately recapitulate the complex biological systems and clinical outcomes of lung cancer. The three-dimensional (3D) cell culture enables the possible 3D cell interactions and the complex 3D systems with co-culture of different cells mimicking the tumor microenvironments (TME). In this regard, patient-derived models, mainly patient-derived tumor xenograft (PDX) and patient-derived organoids discussed hereby, are with higher biological fidelity of lung cancer, and regarded as more faithful preclinical models. The significant Hallmarks of Cancer is believed to be the most comprehensive coverage of current research on tumor biological characteristics. Therefore, this review aims to present and discuss the application of different patient-derived lung cancer models from molecular mechanisms to clinical translation with regards to the dimensions of different hallmarks, and to look to the prospects of these patient-derived lung cancer models.
format Online
Article
Text
id pubmed-9993089
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99930892023-03-09 Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation Song, Yang Wang, Yadong Guan, Ai Xue, Jianchao Li, Bowen Huang, Zhicheng Zheng, Zhibo Liang, Naixin Yang, Yanlian Li, Shanqing Front Bioeng Biotechnol Bioengineering and Biotechnology The conventional two-dimensional (2D) tumor cell lines in Petri dishes have played an important role in revealing the molecular biological mechanism of lung cancer. However, they cannot adequately recapitulate the complex biological systems and clinical outcomes of lung cancer. The three-dimensional (3D) cell culture enables the possible 3D cell interactions and the complex 3D systems with co-culture of different cells mimicking the tumor microenvironments (TME). In this regard, patient-derived models, mainly patient-derived tumor xenograft (PDX) and patient-derived organoids discussed hereby, are with higher biological fidelity of lung cancer, and regarded as more faithful preclinical models. The significant Hallmarks of Cancer is believed to be the most comprehensive coverage of current research on tumor biological characteristics. Therefore, this review aims to present and discuss the application of different patient-derived lung cancer models from molecular mechanisms to clinical translation with regards to the dimensions of different hallmarks, and to look to the prospects of these patient-derived lung cancer models. Frontiers Media S.A. 2023-02-21 /pmc/articles/PMC9993089/ /pubmed/36911198 http://dx.doi.org/10.3389/fbioe.2023.1132940 Text en Copyright © 2023 Song, Wang, Guan, Xue, Li, Huang, Zheng, Liang, Yang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Song, Yang
Wang, Yadong
Guan, Ai
Xue, Jianchao
Li, Bowen
Huang, Zhicheng
Zheng, Zhibo
Liang, Naixin
Yang, Yanlian
Li, Shanqing
Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title_full Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title_fullStr Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title_full_unstemmed Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title_short Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
title_sort footprints: stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993089/
https://www.ncbi.nlm.nih.gov/pubmed/36911198
http://dx.doi.org/10.3389/fbioe.2023.1132940
work_keys_str_mv AT songyang footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT wangyadong footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT guanai footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT xuejianchao footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT libowen footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT huangzhicheng footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT zhengzhibo footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT liangnaixin footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT yangyanlian footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation
AT lishanqing footprintsstampinghallmarksoflungcancerwithpatientderivedmodelsfrommolecularmechanismstoclinicaltranslation